Celldex Therapeutics buy TD Cowen
Start price
20.12.23
/
50%
€35.40
Target price
20.12.24
-
Performance (%)
7.91%
Price
02.05.24
€38.20
Summary
This prediction is currently active. With a performance of 7.91%, the BUY prediction by TD_Cowen for Celldex Therapeutics is trending in the right direction. This prediction currently runs until 20.12.24. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 12.353% | 12.353% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by TD_Cowen for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at TD Cowen. They set an "outperform" rating on the stock.
Ratings data for CLDX provided by MarketBeat